Home › Funds › Caligan Partners LP › TYRA
Caligan Partners LP position in TYRA
TYRA BIOSCIENCES INC · Health Care
Caligan Partners LP reported holding 910,749 shares of TYRA (TYRA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$19.9M, representing 1.22% of its reported portfolio and ranking #20 among its reported holdings. Caligan Partners LP has disclosed TYRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Caligan Partners LP's TYRA position evolved
Caligan Partners LP first disclosed a stake in TYRA in Q1 2025 at 25,000 shares (US$232K). The position peaked in Q1 2026 at 1,276,968 shares, worth US$48.9M. Across 7 filings, Caligan Partners LP increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 910,749 shares valued at US$19.9M — an increase of 103,763 shares quarter over quarter.. Notable position changes include a 660% increase in Q2 2025 (shares rose 46% over the following quarter), a 267% increase in Q3 2025 (shares rose 88% over the following quarter), a 37% trim in Q2 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 25.00K | $232.50K | New |
| Q2 2025 | 189.95K | $1.82M | Add |
| Q3 2025 | 696.83K | $9.75M | Add |
| Q4 2025 | 944.26K | $24.82M | Add |
| Q1 2026 | 1.28M | $48.91M | Add |
| Q2 2026 | 806.99K | $25.78M | Reduce |
| Q3 2026 | 910.75K | $19.92M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TYRA and 13F data
TYRA (TYRA BIOSCIENCES INC) is a Health Care company. 40 other funds we track also report a position in TYRA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$266.8M), BVF INC/IL (US$92.2M), Alta Partners Management Company, L.P. (US$83.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TYRA
- RA CAPITAL MANAGEMENT, L.P. 12.20M sh · $266.78M · Q3 2026
- BVF INC/IL 4.22M sh · $92.20M · Q3 2026
- Alta Partners Management Company, L.P. 3.82M sh · $83.62M · Q3 2026
- Paradigm Biocapital Advisors LP 3.51M sh · $76.77M · Q3 2026
- TCG Crossover Management, LLC 3.48M sh · $76.02M · Q3 2026
- Nextech Invest Ltd. 3.45M sh · $75.40M · Q3 2026
- Siren, L.L.C. 3.40M sh · $74.27M · Q3 2026
- Commodore Capital LP 1.73M sh · $37.73M · Q3 2026
- 5AM Venture Management, LLC 1.03M sh · $22.51M · Q3 2026
- Trails Edge Capital Partners, LP 1.00M sh · $21.87M · Q3 2026
- Affinity Asset Advisors, LLC 850.00K sh · $18.59M · Q3 2026
- Canaan Partners XI LLC 750.00K sh · $16.40M · Q3 2026
More on Caligan Partners LP
FAQ
How long has Caligan Partners LP held TYRA?
Caligan Partners LP has disclosed TYRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Caligan Partners LP's current position in TYRA?
As of Q3 2026, Caligan Partners LP holds 910.75K shares of TYRA (TYRA BIOSCIENCES INC), valued at $19.92M, representing 1.22% of its reported portfolio and ranking #20.
Has Caligan Partners LP been buying or selling TYRA?
In the latest 13F filing (Q3 2026), Caligan Partners LP increased its position in TYRA. The position peaked in Q1 2026 at 1.28M shares.
Which other funds hold TYRA?
Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, Alta Partners Management Company, L.P., among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.